Visualizing the value of diagnostic tests and prediction models, part II. Net benefit graphs: net benefit as a function of the exchange rate

IF 5.2 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Journal of Clinical Epidemiology Pub Date : 2025-05-01 Epub Date: 2025-01-27 DOI:10.1016/j.jclinepi.2025.111690
Michael A. Kohn, Thomas B. Newman
{"title":"Visualizing the value of diagnostic tests and prediction models, part II. Net benefit graphs: net benefit as a function of the exchange rate","authors":"Michael A. Kohn,&nbsp;Thomas B. Newman","doi":"10.1016/j.jclinepi.2025.111690","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Objective</h3><div>In this second of a 3-part series, we move from expected gain in utility (EGU) graphs to net benefit (NB) graphs, which show how NB depends on <strong><em>w</em></strong> <em>= C/B</em>, the treatment threshold odds, equal to the harm of treating unnecessarily (C) divided by the benefit of treating appropriately (B).</div></div><div><h3>Method</h3><div>For NB graphs, we shift from the perspective of testing individual patients with varying pretest probabilities of disease to the perspective of applying a test or risk model to an entire population with a given prevalence of disease, <em>P</em><sub><em>0</em></sub>. As with EGU graphs, we subtract the harm of testing and the expected harm of treating according to the results of a test or model when it is wrong from the expected benefit of treating when it is right. The difference is that for NB graphs, the prevalence is fixed at <em>P</em><sub><em>0</em></sub> , and the x-axis is <strong><em>w</em></strong>. NB graphs show the NB of 3 strategies: 1) “Treat None”; 2) “Test” and treat those with predicted risk greater than the treatment threshold; and 3) “Treat All” in the population regardless of predicted risk.</div></div><div><h3>Results</h3><div>The “Treat All” line intersects the y-axis at NB = <em>P</em><sub><em>0</em></sub> and the x-axis at <em>w</em> = <em>P</em><sub><em>0</em></sub><em>/(1 − P</em><sub><em>0</em></sub><em>)</em>. The “Test” line intersects the “Treat All” line at the Treat–Test threshold value of <strong><em>w</em></strong>; it intersects the x-axis at the <em>Test-No Treat</em> value of <strong><em>w</em></strong>.</div></div><div><h3>Conclusion</h3><div>When NB is plotted as a function of <strong><em>w</em></strong>, NB graphs can be drawn as straight lines from easily calculated intercepts.</div></div>","PeriodicalId":51079,"journal":{"name":"Journal of Clinical Epidemiology","volume":"181 ","pages":"Article 111690"},"PeriodicalIF":5.2000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S089543562500023X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Objective

In this second of a 3-part series, we move from expected gain in utility (EGU) graphs to net benefit (NB) graphs, which show how NB depends on w = C/B, the treatment threshold odds, equal to the harm of treating unnecessarily (C) divided by the benefit of treating appropriately (B).

Method

For NB graphs, we shift from the perspective of testing individual patients with varying pretest probabilities of disease to the perspective of applying a test or risk model to an entire population with a given prevalence of disease, P0. As with EGU graphs, we subtract the harm of testing and the expected harm of treating according to the results of a test or model when it is wrong from the expected benefit of treating when it is right. The difference is that for NB graphs, the prevalence is fixed at P0 , and the x-axis is w. NB graphs show the NB of 3 strategies: 1) “Treat None”; 2) “Test” and treat those with predicted risk greater than the treatment threshold; and 3) “Treat All” in the population regardless of predicted risk.

Results

The “Treat All” line intersects the y-axis at NB = P0 and the x-axis at w = P0/(1 − P0). The “Test” line intersects the “Treat All” line at the Treat–Test threshold value of w; it intersects the x-axis at the Test-No Treat value of w.

Conclusion

When NB is plotted as a function of w, NB graphs can be drawn as straight lines from easily calculated intercepts.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
可视化诊断测试和预测模型的价值,第二部分。净效益图:净效益作为汇率的函数。
背景和目的:在由3部分组成的系列文章的第二部分中,我们将从效用预期收益(EGU)图转向净收益(NB)图,它显示了净收益如何取决于w= C/B,即治疗阈值赔率,等于不必要治疗的危害(C)除以适当治疗的益处(B)。对于NB图,我们从测试具有不同疾病预测试概率的个体患者的角度转变为将测试或风险模型应用于具有给定疾病患病率P0的整个人群的角度。与EGU图一样,我们减去测试的危害和根据测试或模型的结果在错误时进行治疗的预期危害,以及在正确时进行治疗的预期收益。不同的是,对于NB图,患病率固定在P0, x轴为w。NB图显示了3种策略的NB: 1)“治疗”;2)“检测”和治疗那些预测风险大于治疗阈值的人;和3)“治疗所有人”,无论预测风险如何。结果:“治疗全部”线与y轴相交于NB = P0,与x轴相交于w = P0/(1 - P0)。“Test”线与“Treat All”线相交于Treat-Test阈值w处;它与x轴相交于Test-No Treat值w处。结论:当NB作为w的函数绘制时,NB图可以从易于计算的截距绘制为直线。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical Epidemiology
Journal of Clinical Epidemiology 医学-公共卫生、环境卫生与职业卫生
CiteScore
12.00
自引率
6.90%
发文量
320
审稿时长
44 days
期刊介绍: The Journal of Clinical Epidemiology strives to enhance the quality of clinical and patient-oriented healthcare research by advancing and applying innovative methods in conducting, presenting, synthesizing, disseminating, and translating research results into optimal clinical practice. Special emphasis is placed on training new generations of scientists and clinical practice leaders.
期刊最新文献
Artificial intelligence and large language models for interview transcription in qualitative research: competency, politeness, and ethical implications Practical elements to consider when emulating a target trial Crossing the null does not mean “no effect”: a survey of internal medicine physicians on the interpretation of effect estimates with wide confidence intervals Rethinking clinical trials in the multimorbidity era: the imperative for patient-centered tailored approaches Depression rating scales demonstrate significant correlations but systematic differences: a multicenter prospective cohort study using equipercentile linking
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1